A Phase III, Multicenter, Randomized, Double-Blind, Placebo Controlled, Comparative Trial of AMD3100 (Plerixafor)+G-CSF vs. Placebo+G-CSF in Non-Hodgkin’s Lymphoma (NHL) Patients for Autologous Hematopoietic Stem Cell (aHSC) Transplantation.
暂无分享,去创建一个
J. Dipersio | G. Bridger | G. Calandra | P. Stiff | R. Maziarz | B. Bolwell | I. Micallef | Investigators | J. Angell